Axonics Modulation Technologies Stock Book Value Per Share
Axonics Modulation Technologies fundamentals help investors to digest information that contributes to Axonics Modulation's financial success or failures. It also enables traders to predict the movement of Axonics Stock. The fundamental analysis module provides a way to measure Axonics Modulation's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axonics Modulation stock.
Axonics |
Axonics Modulation Technologies Company Book Value Per Share Analysis
Axonics Modulation's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Axonics Modulation Book Value Per Share | 13.00 X |
Most of Axonics Modulation's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axonics Modulation Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Axonics Modulation Technologies is about 13.001 times. This is 864.76% lower than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The book value per share for all United States stocks is 99.33% higher than that of the company.
Axonics Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axonics Modulation's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axonics Modulation could also be used in its relative valuation, which is a method of valuing Axonics Modulation by comparing valuation metrics of similar companies.Axonics Modulation is currently under evaluation in book value per share category among its peers.
Axonics Fundamentals
Return On Equity | -0.0089 | |||
Return On Asset | -0.0063 | |||
Profit Margin | (0.01) % | |||
Operating Margin | (0.02) % | |||
Current Valuation | 3.32 B | |||
Shares Outstanding | 51.11 M | |||
Shares Owned By Insiders | 1.26 % | |||
Shares Owned By Institutions | 87.22 % | |||
Number Of Shares Shorted | 3.31 M | |||
Price To Earning | (10.68) X | |||
Price To Book | 5.46 X | |||
Price To Sales | 8.40 X | |||
Revenue | 366.38 M | |||
Gross Profit | 197.66 M | |||
EBITDA | 7.78 M | |||
Net Income | (6.09 M) | |||
Cash And Equivalents | 213.23 M | |||
Cash Per Share | 4.53 X | |||
Total Debt | 27.62 M | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 10.49 X | |||
Book Value Per Share | 13.00 X | |||
Cash Flow From Operations | (2.02 M) | |||
Short Ratio | 7.14 X | |||
Earnings Per Share | (0.10) X | |||
Price To Earnings To Growth | (0.56) X | |||
Target Price | 72.0 | |||
Number Of Employees | 797 | |||
Beta | 0.83 | |||
Market Capitalization | 3.63 B | |||
Total Asset | 719.92 M | |||
Retained Earnings | (380.35 M) | |||
Working Capital | 445.61 M | |||
Current Asset | 171.14 M | |||
Current Liabilities | 12.98 M | |||
Net Asset | 719.92 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.ZLAB | Zai Lab | |
ASLE | AerSale Corp | |
ATS | AT S Austria |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |